Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Wedbush raises PTGX target to 173; posted price 149.51; priceChangeSinceSignal 0.33.
Target: $173
Posted price: $149.51
Analyst firm: Wedbush
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.